p53-expressing oncolytic adenoviruses (ORCA Therapeutics)

N/A

Report date: 2025/06/11 10:19:32

Base Information

Drug Namep53-expressing oncolytic adenoviruses (ORCA Therapeutics)
Drug Alias Nameoncolytic adenovirus therapy expressing p53 (ORCA Therapeutics)AdDelta24-425S11AdDelta24-p53
ClassificationBiologics > Oncolytic virus
Mechanisms of ActionImmunostimulantsTumor protein p53 stimulants
TargetsTumor protein p53
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNetherlands
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesOrca Therapeutics Bv
China Registration ClassN/A

Develop Information

Active CompaniesOrca Therapeutics Bv
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A